Episode Details

Weight-loss drugs like Ozempic, Mounjaro, and Wegovy are revolutionizing obesity treatment worldwide, including in Ireland, where adult obesity stands at twenty-one percent. These GLP-one meds, which mimic a hormone that signals fullness, have led to a decrease in obesity rates and improved health. However, they come with challenges such as high costs, potential side effects, and the need for lifelong use. Despite these hurdles, the potential benefits, including cost savings and improved wellness, make them a promising tool in the fight against obesity.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d9a6b61c70e5fbf9